Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NBY | US
0.11
7.75%
Healthcare
Biotechnology
30/06/2024
26/03/2026
1.53
1.44
1.70
1.44
NovaBay Pharmaceuticals Inc. a biopharmaceutical company develops and sells eyecare skincare and wound care products in the United States and internationally. It offers Avenova Spray a solution for removing foreign materials including microorganisms and debris from skin around the eye such as the eyelid; and wound care products which are used for cleansing and irrigation as part of surgical procedures as well as treating certain wounds burns ulcers and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris rosacea and eczema anti-aging hyperhidrosis excessive hair and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors as well as online. The company was formerly known as NovaCal Pharmaceuticals Inc. and changed its name to NovaBay Pharmaceuticals Inc. in February 2007. NovaBay Pharmaceuticals Inc. was incorporated in 2000 and is headquartered in Emeryville California.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
179.9%1 month
152.3%3 months
329.5%6 months
281.3%-
-
0.29
-3.26
0.51
-0.34
0.30
-
-5.03M
7.48M
7.48M
-
-43.88
-
-32.10
-282.96
0.06
9.25
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.72
Range1M
1.02
Range3M
19.52
Rel. volume
0.53
Price X volume
552.82K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| BioAtla Inc. | BCAB | Biotechnology | 0.17 | 8.22M | 7.53% | n/a | 5.30% |
| Ensysce Biosciences Inc | ENSC | Biotechnology | 0.547 | 7.59M | -1.94% | n/a | 24.79% |
| CollPlant Holdings Ltd | CLGN | Biotechnology | 0.66 | 7.56M | -12.02% | n/a | 0.00% |
| Moleculin Biotech Inc | MBRX | Biotechnology | 2.43 | 6.91M | -2.41% | n/a | 3.00% |
| Common Stock | ADXN | Biotechnology | 6.3 | 6.73M | -3.15% | n/a | 0.25% |
| Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.5 | 6.71M | -22.28% | n/a | 0.00% |
| Purple Biotech Ltd | PPBT | Biotechnology | 3.99 | 6.29M | -3.62% | n/a | 0.89% |
| CALC | CALC | Biotechnology | 0.5825 | 6.26M | 1.13% | n/a | 0.00% |
| Cadrenal Therapeutics Inc. Common Stock | CVKD | Biotechnology | 5.24 | 6.19M | -3.32% | n/a | 0.22% |
| Oragenics Inc | OGEN | Biotechnology | 0.5782 | 6.09M | -7.34% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 3.64 | 5.54M | -1.62% | n/a | 204.46% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.37 | 3.52M | 1.54% | n/a | 19.98% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.23 | 3.14M | -4.65% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.02 | 1.11M | 1.00% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0084 | 774.60K | 20.00% | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.34 | - | Cheaper |
| Ent. to Revenue | 0.30 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.29 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 329.49 | - | Riskier |
| Debt to Equity | -3.26 | -1.23 | Cheaper |
| Debt to Assets | 0.51 | 0.25 | Expensive |
| Market Cap | 7.48M | - | Emerging |